SCHEMBL20370696

SCHEMBL20370696

c1ccc2nc3c(nc2c1)Sc1ccc(-c2c4ccccc4c(-c4ccncc4)c4ccccc24)cc1S3

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPK14 Q16539 2/20 0.38
▸ MAPK10 P53779 1/20 0.38
▸ DHODH Q02127 1/20 0.37
▸ ESR1 P03372 2/20 0.35
▸ ESR2 Q92731 2/20 0.35
▸ KDM4E B2RXH2 2/20 0.35
▸ NPC1 O15118 2/20 0.35
▸ RAB9A P51151 2/20 0.35
▸ PDGFRB P09619 1/20 0.35
▸ PDGFRA P16234 1/20 0.35
▸ MAPT P10636 3/20 0.35
▸ APOBEC3G Q9HC16 3/20 0.35
▸ ALDH1A1 P00352 2/20 0.35
▸ HPGD P15428 2/20 0.35
▸ ALOX15 P16050 1/20 0.35
▸ HSD17B10 Q99714 1/20 0.35
▸ MEN1 O00255 4/20 0.34
▸ KMT2A Q03164 4/20 0.34
▸ MAPK1 P28482 1/20 0.34
▸ RECQL P46063 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20370697 0.89 DHODH (0.38) MAPK14MAPK10DHODHKDM4ENPC1
SCHEMBL20370716 0.87 DHODH (0.38) MAPK14MAPK10DHODHESR1ESR2
SCHEMBL20370681 0.86 PIK3CA (0.40) MAPK14MAPK10DHODHKDM4ENPC1
SCHEMBL20370665 0.83 MEN1 (0.39) KDM4EMAPTALDH1A1HSD17B10MEN1
SCHEMBL20370740 0.82 CYP11B1 (0.41) DHODHKDM4ENPC1RAB9AMAPT
SCHEMBL20370683 0.82 CYP11B1 (0.43) DHODHNPC1RAB9APDGFRBPDGFRA
SCHEMBL20370672 0.81 MEN1 (0.40) ESR1ESR2KDM4EMAPTALDH1A1
SCHEMBL20370695 0.81 MEN1 (0.37) ESR1ESR2KDM4ERAB9AMAPT
SCHEMBL20370692 0.81 RAB9A (0.43) MAPK14MAPK10DHODHKDM4ENPC1
SCHEMBL20370686 0.80 ACHE (0.39) DHODHESR1ESR2KDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10854823-B2 Heterocyclic compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-12-01 — — US disclosed
US-20180198074-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2018-07-12 — — US disclosed
US-20180198074-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2018-07-12 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10854823-B2 Heterocyclic compound and organic light-emitting device including the same CRY1, CRY2, CYP1A1 MAPK14 3754/4885MAPK10 3914/4885DHODH 141/4885
US-20180198074-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CYP1A1 MAPK14 3754/4885MAPK10 3914/4885DHODH 141/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback